[1] Zhang M, Jing Y, Xu W, et al. The C-type lectin COLEC10 is predominantly produced by hepatic stellate cells and involved in the pathogenesis of liver fibrosis. Cell Death Dis, 2023,14(11):785.
[2] Ginès P, Krag A, Abraldes J G, et al. Liver cirrhosis. Lancet, 2021,398(10308):1359-1376.
[3] Kim H Y, Yu J H, Chon Y E, et al. Prevalence of clinically significant liver fibrosis in the general population: a systematic review and meta-analysis. Clin Mol Hepatol, 2024,30(Suppl):S199-S213.
[4] Liu Y, Zheng Y, Yang Y, et al. Exosomes in liver fibrosis: the role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications. Front Immunol, 2023,14:1133297.
[5] Shen J, Cao J, Chen M, et al. Recent advances in the role of exosomes in liver fibrosis. J Gastroenterol Hepatol, 2023,38(7):1083-1088.
[6] Wu B, Feng J, Guo J, et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. Stem Cell Res Ther, 2022,13(1):494.
[7] Shelke G V, Williamson C D, Jarnik M, et al. Inhibition of endolysosome fusion increases exosome secretion. J Cell Biol, 2023,222(6):e202209084.
[8] Savina A, Fader C M, Damiani M T, et al. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic, 2005,6(2):131-143.
[9] Sundar V, Saraswathi V. Effect of ethanol on exosome biogenesis: possible mechanisms and therapeutic implications. Biomolecules, 2023,13(2):222.
[10] Gurunathan S, Kang M, Jeyaraj M, et al. Platinum nanoparticles enhance exosome release in human lung epithelial adenocarcinoma cancer cells (A549): oxidative stress and the ceramide pathway are key players. Int J Nanomedicine, 2021,16:515-538.
[11] Chen Y, Zhao Y, Yin Y, et al. Mechanism of cargo sorting into small extracellular vesicles. Bioengineered, 2021,12(1):8186-8201.
[12] Thietart S, Rautou P. Extracellular vesicles as biomarkers in liver diseases: a clinician's point of view. J Hepatol, 2020,73(6):1507-1525.
[13] Mirzaei R, Karampoor S, Korotkova N L. The emerging role of miRNA-122 in infectious diseases: mechanisms and potential biomarkers. Pathol Res Pract, 2023,249:154725.
[14] Suga K, Matsui D, Watanabe N, et al. Insight into the exosomal membrane: from viewpoints of membrane fluidity and polarity. Langmuir, 2021,37(38):11195-11202.
[15] Rincón-Riveros A, Lopez L, Villegas E V, et al. Regulation of antitumor immune responses by exosomes derived from tumor and immune cells. Cancers (Basel), 2021,13(4):847.
[16] Hong Y, Ye M, Wang F, et al. MiR-21-3p promotes hepatocellular carcinoma progression via SMAD7/YAP1 regulation. Front Oncol, 2021,11:642030.
[17] Rodrigues P M, Afonso M B, Simão A L, et al. MiR-21-5p promotes NASH-related hepatocarcinogenesis. Liver Int, 2023,43(10):2256-2274.
[18] Chen K, Lin T, Yao W, et al. Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1. Gastroenterol Hepatol, 2023,46(7):531-541.
[19] Ma L, Song H, Zhang C, et al. MiR-192-5p Ameliorates hepatic lipid metabolism in non-alcoholic fatty liver disease by targeting Yy1. Biomolecules, 2023,14(1):34.
[20] Lang Z, Li Y, Lin L, et al. Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells. Cell Death Discov, 2023,9(1):304.
[21] Dong Z, Yang X, Qiu T, et al. Exosomal miR-181a-2-3p derived from citreoviridin-treated hepatocytes activates hepatic stellate cells trough inducing mitochondrial calcium overload. Chem Biol Interact, 2022,358:109899.
[22] Luo X, Luo S, Xu Z, et al. Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World J Gastroenterol, 2021,27(14):1419-1434.
[23] Liu B, Wang J, Wang G, et al. Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation. Int Immunopharmacol, 2023,115:109605.
[24] Ye Q, Zhou Y, Zhao C, et al. Salidroside inhibits CCl(4)-induced liver fibrosis in mice by reducing activation and migration of HSC induced by liver sinusoidal endothelial cell-derived exosomal SphK1. Front Pharmacol, 2021,12:677810.
[25] Xu W, Mo W, Han D, et al. Hepatocyte-derived exosomes deliver the lncRNA CYTOR to hepatic stellate cells and promote liver fibrosis. J Cell Mol Med, 2024,28(8):e18234.
[26] Seo W, Eun H S, Kim S Y, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis. Hepatology, 2016,64(2):616-631.
[27] Van Meteren N, Lagadic-Gossmann D, Podechard N, et al. Extracellular vesicles released by polycyclic aromatic hydrocarbons-treated hepatocytes trigger oxidative stress in recipient hepatocytes by delivering iron. Free Radic Biol Med, 2020,160:246-262.
[28] Hirsova P, Gores G J. Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol, 2015,1(1):17-27.
[29] Chen Y, Yang F, Wang Y, et al. Mesenchymal stem cell-derived small extracellular vesicles reduced hepatic lipid accumulation in MASLD by suppressing mitochondrial fission. Stem Cell Res Ther, 2025,16(1):116.
[30] Zhang L, Wang C, Hu W, et al. Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE(-/-) mice with minimal side effects. Theranostics, 2023,13(14):5114-5129.
[31] Fukushima M, Dasgupta D, Mauer A S, et al. StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis. J Biol Chem, 2018,293(39):15277-15289.
[32] Du Y, Li Z. Cystatin C alleviates unconjugated bilirubin-induced neurotoxicity by promoting bilirubin clearance from neurocytes via exosomes, dependent on hepatocyte UGT1A1 activity. Transl Neurosci, 2024,15(1):20220357.
[33] Liao T, Chen Y, Hsieh S, et al. Hepatitis C virus-induced exosomal microRNAs and toll-like receptor 7 polymorphism regulate B-cell activating factor. mBio, 2021,12(6):e276421.
[34] Qu M, Zhu H, Zhang X. Extracellular vesicle-mediated regulation of macrophage polarization in bacterial infections. Front Microbiol, 2022,13:1039040.
[35] Costa-Silva B, Aiello N M, Ocean A J, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol, 2015,17(6):816-826.
[36] Luo X, Xu Z, Wu J, et al. Hepatocyte-derived exosomal miR-27a activateshepatic stellate cells through the inhibitionof PINK1-mediated mitophagy in MAFLD. Mol Ther Nucleic Acids, 2021,26:1241-1254.
[37] Li S, Cheng F, Zhang Z, et al. The role of hepatocyte-derived extracellular vesicles in liver and extrahepatic diseases. Biomed Pharmacother, 2024,180:117502.
[38] Li Y, Wu J, Liu R, et al. Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases. Theranostics, 2022,12(16):6955-6971.
[39] Munsterman I D, Kendall T J, Khelil N, et al. Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease. Histopathology, 2018,73(4):612-621.
[40] Wang X, Seo W, Park S H, et al. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types. Int J Biol Sci, 2021,17(4):1153-1167.
[41] Parlatan U, Ozen M O, Kecoglu I, et al. Label-free identification of exosomes using raman spectroscopy and machine learning. Small, 2023,19(9):e2205519.
[42] 孙东磊,郭金波,王丹丹,等.间充质干细胞外泌体对体外肝星状细胞增殖和活化的影响.实用肝脏病杂志,2023,26(1):11-14.
[43] 张文彦,刘芳,刘梦露,等.非酒精性脂肪性肝病患者血浆外泌体差异蛋白分析.实用肝脏病杂志,2022,25(4):521-525.
[44] Bhadra M, Sachan M. An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection. Heliyon, 2024,10(9):e30328. |
